STOCK TITAN

McKesson Corporation - MCK STOCK NEWS

Welcome to our dedicated page for McKesson Corporation news (Ticker: MCK), a resource for investors and traders seeking the latest updates and insights on McKesson Corporation stock.

McKesson Corporation (symbol: MCK) is a leading healthcare services and information technology company, dedicated to improving the business of healthcare globally. Ranked 11th on the Fortune 500 list, McKesson collaborates with a diverse range of stakeholders including payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and other entities across the healthcare spectrum. The company's mission is to foster healthier organizations that deliver superior care to patients in every setting.

McKesson is one of the top three pharmaceutical wholesalers in the United States, engaging in the sourcing and distribution of branded, generic, and specialty pharmaceutical products. Their extensive client base includes retail chains, independent pharmacies, mail-order pharmacies, hospital networks, and healthcare providers. Alongside Cencora and Cardinal Health, McKesson commands over 90% of the US pharmaceutical wholesale industry.

Beyond the US, McKesson's reach extends to Canada, where they are involved in pharmaceutical wholesale and distribution. Additionally, McKesson supplies medical-surgical products and equipment to healthcare facilities and offers a range of technology solutions tailored for pharmacies.

McKesson's comprehensive service offerings include pharmaceutical and medical-surgical supply management, healthcare information technology solutions, and business and clinical services. The company is committed to helping its customers enhance their financial, operational, and clinical performance, ultimately aiming to deliver better patient care.

Recent achievements include strategic partnerships and innovative projects that continue to position McKesson as a key player in the healthcare industry. Their ongoing projects are designed to streamline operations and improve efficiency across the board, ensuring that healthcare providers can focus on patient care.

For more details on McKesson Corporation, visit www.mckesson.com.

Rhea-AI Summary
McKesson (NYSE:MCK) announces a quarterly dividend of 62 cents per share of common stock, payable on July 1, 2024, to stockholders of record on June 3, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.64%
Tags
dividends
-
Rhea-AI Summary
McKesson (MCK) is set to announce its fourth quarter and full year fiscal 2024 financial results on May 7, 2024. Investors can join the live webcast at 4:30 PM Eastern Time to review the company's performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.45%
Tags
-
Rhea-AI Summary
McKesson Corporation (MCK) has released its fiscal 2024 third-quarter financial results. The company will host a live webcast of the earnings conference call for investors on February 7th at 4:30 PM ET to review its financial results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.4%
Tags
Rhea-AI Summary
McKesson Corporation (MCK) declared a regular dividend of 62 cents per share of common stock, payable on April 1, 2024, to stockholders of record on March 1, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.39%
Tags
dividends
-
Rhea-AI Summary
McKesson Corporation (MCK) adds new director and announces the acquisition of Compile, a healthcare data platform, at the 42nd Annual J.P. Morgan Healthcare Conference. Kevin Ozan joins the board of directors, increasing the number to 12. Ozan, a former executive at McDonald's, brings extensive leadership experience in strategy and finance. The acquisition of Compile is expected to enhance McKesson's commercial data platform and provide insights to biopharma customers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.93%
Tags
conferences
-
Rhea-AI Summary
McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024. The company will host a live webcast of the earnings conference call for investors at 4:30 PM Eastern Time to review its financial results. McKesson management will be participating in the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
McKesson Corporation (NYSE: MCK) has released its fiscal 2024 second quarter financial results. The results can be accessed on McKesson’s Investor Relations website. The company will host a live webcast of the earnings conference call for investors today. The audio webcast of the conference call will be available live and archived on McKesson's Investor Relations website, along with the company’s earnings press release, financial tables, and slide presentation.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.61%
Tags
-
Rhea-AI Summary
McKesson Corporation (NYSE:MCK) declares regular dividend of 62 cents per share of common stock.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.3%
Tags
dividends
-
Rhea-AI Summary
KORU Medical Systems appoints Edward Wholihan to its Board of Directors, bringing over 25 years of experience as CFO in the life sciences and healthcare sectors. His insights are expected to contribute to the company's future growth and success.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.87%
Tags
management
Rhea-AI Summary
McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2024 financial results after market close on Wednesday, November 1, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags

FAQ

What is the current stock price of McKesson Corporation (MCK)?

The current stock price of McKesson Corporation (MCK) is $621.14 as of November 20, 2024.

What is the market cap of McKesson Corporation (MCK)?

The market cap of McKesson Corporation (MCK) is approximately 80.5B.

What services does McKesson Corporation provide?

McKesson provides pharmaceutical and medical-surgical supply management, healthcare information technology solutions, and business and clinical services.

Where does McKesson Corporation operate?

McKesson operates primarily in the United States and Canada, supplying pharmaceutical and medical-surgical products and providing healthcare IT solutions.

Who are McKesson's primary clients?

McKesson's clients include payers, hospitals, physician offices, pharmacies, pharmaceutical companies, and other healthcare providers.

What makes McKesson a leading pharmaceutical wholesaler?

McKesson's significant market share, along with its partnerships with Cencora and Cardinal Health, allows it to command over 90% of the US pharmaceutical wholesale industry.

How does McKesson help improve healthcare delivery?

McKesson enhances healthcare delivery by providing products and technology solutions that improve the financial, operational, and clinical performance of healthcare providers.

What are some recent achievements of McKesson Corporation?

Recent achievements include strategic partnerships and innovative projects aimed at streamlining operations and improving efficiency in healthcare delivery.

Can individuals buy products directly from McKesson?

McKesson primarily serves healthcare providers and does not sell products directly to individual consumers.

How does McKesson contribute to the healthcare industry?

McKesson contributes by ensuring efficient distribution of pharmaceuticals, providing essential medical-surgical products, and offering technology solutions for better healthcare management.

What is the significance of McKesson's partnerships?

McKesson's partnerships allow the company to expand its reach, improve service delivery, and ensure better patient care across various healthcare settings.

Where can I find more information about McKesson Corporation?

For more information, visit McKesson's official website at www.mckesson.com.

McKesson Corporation

NYSE:MCK

MCK Rankings

MCK Stock Data

80.47B
129.54M
0.1%
89.58%
1.61%
Medical Distribution
Wholesale-drugs, Proprietaries & Druggists' Sundries
Link
United States of America
IRVING